Interestingly, the expression levels of c-Abl and p53 are inversely correlated in bone marrow, a tissue wherein c-Abl acquires oncogenic activity during the initiation of CML [17, 18]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.